Hawaii · 2026 Regular Session · Bill
SB 3195: RELATING TO DRUGS FOR WEIGHT LOSS.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 3195 is a bill introduced in the Hawaii Senate on January 28, 2026. According to its official title, it concerns: RELATING TO DRUGS FOR WEIGHT LOSS. Primary sponsor: Kurt Fevella (Republican), Brenton Awa (Republican), Stanley Chang (Democratic). It lists 2 additional sponsors. Most recent recorded action (February 2, 2026): Referred to HHS, WAM.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Requires the Department of Human Services to provide Medicaid and Medicare part D prescription drug program recipients with coverage of glucagon-like peptide-1 (GLP-1) drugs for weight loss. Appropriates funds.
Sponsors
Sponsors by party (alphabetical): Democratic 3 · Republican 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Kurt Fevella | Primary sponsor | Republican | Senate | 20 |
| Brenton Awa | Primary sponsor | Republican | Senate | 23 |
| Stanley Chang | Primary sponsor | Democratic | Senate | 9 |
| Rachele Lamosao | Co-sponsor | Democratic | Senate | 19 |
| Angus McKelvey | Co-sponsor | Democratic | Senate | 6 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Referred to HHS, WAM.
- Introduced.
- Passed First Reading.